1. Home
  2. Labeler Index
  3. Sanofi-aventis U.s. Llc
  4. 0024-5745
  5. NDC Package Code: 0024-5745-02 Adlyxin

NDC Package 0024-5745-02 Adlyxin

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0024-5745-02
Package Description:
1 KIT in 1 CARTON * 3 mL in 1 SYRINGE (0024-5741-01) * 3 mL in 1 SYRINGE (0024-5740-00)
Product Code:
0024-5745
Proprietary Name:
Adlyxin
Usage Information:
Lixisenatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Lixisenatide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high sugar levels (such as after a meal) and decreasing the amount of sugar your liver makes. Lixisenatide is not a substitute for insulin if you require insulin treatment.
11-Digit NDC Billing Format:
00024574502
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Labeler Name:
Sanofi-aventis U.s. Llc
Sample Package:
No
FDA Application Number:
BLA208471
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
07-27-2016
End Marketing Date:
09-30-2023
Listing Expiration Date:
09-30-2023
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0024-5745-02?

The NDC Packaged Code 0024-5745-02 is assigned to a package of 1 kit in 1 carton * 3 ml in 1 syringe (0024-5741-01) * 3 ml in 1 syringe (0024-5740-00) of Adlyxin, labeled by Sanofi-aventis U.s. Llc. The product's dosage form is and is administered via form.

Is NDC 0024-5745 included in the NDC Directory?

No, Adlyxin with product code 0024-5745 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Sanofi-aventis U.s. Llc on July 27, 2016 and its listing in the NDC Directory is set to expire on September 30, 2023 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 0024-5745-02?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 0024-5745-02?

The 11-digit format is 00024574502. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20024-5745-025-4-200024-5745-02